MariNakazawaMD

PubMed

• Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC.
  Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J F...> ;Cancer Research Communications. 2024 Mar 14
• Case Series of Men with the Germline APC I1307K variant and Treatment-Emergent Neuroendocrine Prostate Cancer.
  Minas P Economides, Mari Nakazawa, Jonathan W Lee, Xiaochun Li, Lucas Hollifield, Rachelle Chambers, Michal Sarfaty, Judith D Goldberg, Emmanuel S Antonarakis, David R...> ;Clinical Genitourinary Cancer. 2024 Feb 1
• 8 citations
  Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Shedding in a Patient With AIDS: Case Report and Review of the Literature.
  Jillian L Peters, Amary Fall, Steven D Langerman, Margueritta El Asmar, Mari Nakazawa, Aishat Mustapha, Aaron A R Tobian, Heba H Mostafa, Joel N Blankson> ;Open Forum Infectious Diseases. 2022 Sep 1
• 16 citations
  Clinical and genomic features of SPOP-mutant prostate cancer.
  Mari Nakazawa, Mike Fang, Catherine Handy Marshall, Tamara L. Lotan, Pedro Isaacsson Velho, Emmanuel S. Antonarakis> ;The Prostate. 2021 Nov 15
• 27 citations
  Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.
  Elisa Ledet, Earle F. Burgess, Alexandra O. Sokolova, Ellen Jaeger, Whitley Hatton, Marcus Marie Moses, Patrick J. Miller, Patrick Cotogno, Jodi Lyn Layton, Pedro C. B...> ;The Prostate. 2021 May 1
• Efficacy of Abiraterone and Enzalutamide in Pre- and Postdocetaxel Castration-Resistant Prostate Cancer: A Trial-Level Meta-Analysis.
  Fang, M.,Nakazawa, M.,Antonarakis, E. S.,Li, C.> ;Prostate Cancer. 2018 Jan 24
• Mechanisms of Therapeutic Resistance in Prostate Cancer.
  Nakazawa, M.,Paller, C.,Kyprianou, N.> ;Curr Oncol Rep. 2017 Feb 24
• Suprarenal Neuroblastoma Presenting in a Child With Infantile Scoliosis.
  Nakazawa, M.,Crook, S.,Horan, J.,D Orazio, J.> ;Pediatr Blood Cancer. 2015 Nov 18
• Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer.
  Antonarakis ES Lu C Luber B Wang H Chen Y Nakazawa M Nadal R Paller CJ Denmeade SR Carducci MA Eisenberger MA Luo J> ;JAMA Oncol. 2015 Aug
• Resistance to androgen-pathway drugs in prostate cancer.
  Antonarakis ES Nakazawa M Luo J> ;N Engl J Med. 2014 Dec 4
• Androgen receptor splice variants in the era of enzalutamide and abiraterone.
  Nakazawa M Antonarakis ES Luo J> ;Horm Cancer. 2014 Oct
• AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
  Antonarakis ES Lu C Wang H Luber B Nakazawa M Roeser JC Chen Y Mohammad TA Chen Y Fedor HL Lotan TL Zheng Q De Marzo AM Isaacs JT Isaacs WB Nadal R Pal...> ;N Engl J Med. 2014 Sep 11
• Join now to see all